Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-757 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-1804 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-757 |
filingDate |
1994-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ef301ef6cab3e62a5eb5309972f269a |
publicationDate |
1995-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AP-9400618-A0 |
titleOfInvention |
Benzylimidazopyridine derivative as angiotensin 11 receptor antagonist. |
abstract |
1-[4'-(2"-Ethyl-5",7"-dimethylimidazo[4,5-b]pyridin-3-yl)methylphenyl]cyclopent-3-ene-1-carboxylic acid and its pharmaceutically acceptable salts inhibit angiotensin ll in mammals and useful in treating conditions such as hypertension, congestive heart failure and glaucoma and as the active ingredient in pharmaceutical compositions for treating such conditions. |
priorityDate |
1993-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |